Bicoll News

EIT Health Summit 2019

Bicoll is excited to join the EIT Health Summit 2019 which will be held on December 2nd and 3rd 2019 at the Palais Brongniart in Paris, France. EIT Health is a network of best-in-class health innovators backed by the EU. …

Read more

Natural based medicinal chemistry

Medicinal Chemistry & Synthesis: Bicoll seamlessly guides your synthesis and lead optimization projects through drug discovery and development with intensive understanding of structure-activity relationships, capability in biological data
interpretation, solid knowledge of intellectual property and patent aspects. Reliable and fast reporting …

Read more

B2B… means Bicoll goes BioJapan 2019

Bicoll is happy to announce its participation at BioJapan 2019. Like previous year (BioJapan2018) we are happy to welcome you under the roof of German Pavilion from October 9th to 11th in Yokohama. Partnering is open, so make your appointment …

Read more

12th Wartburg Symposium on Flavor Chemistry & Biology

Eisenach, Germany, May 21 – 24, 2019 Cutting-edge research in taste and smell returns once more to the beautiful “Hotel on the Wartburg” in Eisenach, Germany. Since its inception in 1978, the Wartburg Symposium on Flavor Chemistry & Biology has …

Read more

Business Conference in Ibaraki, Japan

Tsukuba, Ibaraki – Bicoll presents at Ibaraki Business conference, February 19-20, 2019 On February 19 (Tue.) and 20 (Wed.), 2019, the Ministry of Economy, Trade and Industry (METI), the Japan External Trade Organization (JETRO) and Ibaraki Prefecture will jointly hold …

Read more

RINK Festival 2019, Kawasaki, Japan

Kawasaki, Kanagawa, February 8 2019 – Bicoll joins RINK Festival 2019 with video presentation. RINK is a network that has been established for the purpose of creating innovation by companies located in the Life Innovation Center (LIC), a center located …

Read more

EpimiRNA FP7 Grant: working to improve lives of patients

Bicoll brings in its medicinal chemistry competence as an active participant of EpimiRNA project. A first novel lead structure preventing seizures in a human tissue model could be provided through the consortium efforts. Furthermore, there are a number of results …

Read more

China Biotech revolution, special edition

China Biotech revolution, special edition: “Bicoll is the first German-Chinese biotech company.” (Dr. Kai Lamottke, Bicoll GmbH, CEO). Those who missed the printed version – order the e-paper in German or Chinese PDF Download (German)